The effects of aromatase inhibitors on lipids and thrombosis

por Bundred, N J
Publicado 2005

Potential use of COX-2–aromatase inhibitor combinations in breast cancer

por Bundred, N J, Barnes, N L P
Publicado 2005

Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.

por Walls, J., Ratcliffe, W. A., Howell, A., Bundred, N. J.
Publicado 1994

Assessment of apoptosis in human breast tissue using an antibody against the active form of caspase 3: relation to tumour histopathological characteristics

por Hadjiloucas, I, Gilmore, A P, Bundred, N J, Streuli, C H
Publicado 2001

Epithelial proliferation and hormone receptor status in the normal post-menopausal breast and the effects of hormone replacement therapy.

por Hargreaves, D. F., Knox, F., Swindell, R., Potten, C. S., Bundred, N. J.
Publicado 1998

Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence

por Barnes, N, Haywood, P, Flint, P, Knox, W F, Bundred, N J
Publicado 2006

Evidence of significant apoptosis in poorly differentiated ductal carcinoma in situ of the breast.

por Gandhi, A., Holland, P. A., Knox, W. F., Potten, C. S., Bundred, N. J.
Publicado 1998

COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ

por Boland, G P, Butt, I S, Prasad, R, Knox, W F, Bundred, N J
Publicado 2004

Hormonally-regulated proteins in breast secretions are markers of target organ sensitivity

por Harding, C, Osundeko, O, Tetlow, L, Faragher, E B, Howell, A, Bundred, N J
Publicado 2000

Is there an increased risk of breast cancer in women who have had a breast cyst aspirated?

por Bundred, N. J., West, R. R., Dowd, J. O., Mansel, R. E., Hughes, L. E.
Publicado 1991

Tumour cyclic AMP binding proteins and endocrine responsiveness in patients with inoperable breast cancer.

por Watson, D. M., Hawkins, R. A., Bundred, N. J., Stewart, H. J., Miller, W. R.
Publicado 1987

The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells

por Hoey, R P, Sanderson, C, Iddon, J, Brady, G, Bundred, N J, Anderson, N G
Publicado 2003

Reply: PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide?

por Hoey, R P, Sanderson, C, Iddon, J, Brady, G, Bundred, N J, Anderson, N G
Publicado 2004

A comparison of axillary node status between cancers detected at the prevalence and first incidence breast screening rounds.

por Holland, P. A., Walls, J., Boggis, C. R., Knox, F., Baildam, A. D., Bundred, N. J.
Publicado 1996

The importance of complete excision in the prevention of local recurrence of ductal carcinoma in situ.

por Holland, P. A., Gandhi, A., Knox, W. F., Wilson, M., Baildam, A. D., Bundred, N. J.
Publicado 1998

Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases

por Walls, J, Assiri, A, Howell, A, Rogers, E, Ratcliffe, W A, Eastell, R, Bundred, N J
Publicado 1999

Biological response to hormonal manipulation in oestrogen receptor positive ductal carcinoma in situ of the breast

por Boland, G P, Mckeown, A, Chan, K C, Prasad, R, Knox, W F, Bundred, N J
Publicado 2003

Is apocrine differentiation in breast carcinoma of prognostic significance?

por Bundred, N. J., Walker, R. A., Everington, D., White, G. K., Stewart, H. J., Miller, W. R.
Publicado 1990

Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer

por Barnes, N L P, Warnberg, F, Farnie, G, White, D, Jiang, W, Anderson, E, Bundred, N J
Publicado 2007

Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity

por Wilson, G R, Cramer, A, Welman, A, Knox, F, Swindell, R, Kawakatsu, H, Clarke, R B, Dive, C, Bundred, N J
Publicado 2006